Tag: HealthLaw
Executive Fired After Opposing 5,000% Drug Price Hike
News
A former vice president of the drugmaker that drew national criticism for raising the price of a parasite-fighting medication by 5,000% testified he was fired weeks after telling CEO Martin Shkreli the increase “was not justified,” reports USA Today.
Celgene Announces Settlement of REVLIMID Patent Litigation
NEWS
Celgene has agreed to provide Natco with a license to Celgene’s patents required to manufacture and sell an unlimited quantity of generic lenalidomide.
